πŸ‡ΊπŸ‡Έ FDA
Patent

US 8642770

Indole derivative

granted A61PA61P3/04A61P43/00

Quick answer

US patent 8642770 (Indole derivative) held by Takeda Pharmaceutical Company Limited expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P3/04, A61P43/00